1.Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms.
Yu Jun WONG ; Karen Jui Lin CHOO ; Jade Xiao Jue SOH ; Chee Kiat TAN
Singapore medical journal 2018;59(1):112-113
Adult
;
Cytomegalovirus
;
Cytomegalovirus Infections
;
complications
;
Drug Hypersensitivity Syndrome
;
complications
;
virology
;
Eosinophilia
;
complications
;
virology
;
Fatal Outcome
;
Female
;
Gout
;
drug therapy
;
Hepatitis
;
complications
;
virology
;
Humans
;
Liver
;
physiopathology
;
Viremia
2.Clinical observation of cholestatic liver disease caused by cytomegalovirus infection treated by lidan mixture: a case report of 120 infants.
Su-qi YAN ; Yu-ping DENG ; Jian-qiao TANG
Chinese Journal of Integrated Traditional and Western Medicine 2012;32(12):1632-1637
OBJECTIVETo observe the clinical effects of Linda Mixture (LM) on cholestatic liver diseases caused by cytomegalovirus (CMV) infection.
METHODSTotally 240 CMV infected cholestatic liver diseases infants, who were hospitalized at the Department of Integrated Traditional Chinese and Western Medicine, Wuhan Children's Hospital from January 2008 to June 2011, were randomly assigned to the treatment group (120 cases) and the control group (120 cases). Patients in the treatment group were treated by LM combined ganciclovir, while those in the control group were treated by ganciclovir alone. The therapeutic course was 2 months. The patients were assigned to 3 sub-groups according to the quantification standards of symptoms and signs, i. e., the No. 1 treatment group (mild, 30 cases), the No. 1 control group (mild, 30 cases), the No. 2 treatment group (moderate, 30 cases), the No. 2 control group (moderate, 30 cases), the No. 3 treatment group (severe, 30 cases), the No. 1 control group (severe, 30 cases). The clinically cured rate and the total effective rate, the jaundice subside time, the retraction time for Gan and Pi, the body weight growth, the indices of the liver function, and lab indices of CMV infection were observed before and after treatment.
RESULTSAfter treatment the cured rate was 77.50% and the total effective rate was 88.33% in the treatment group, while they were 60.83% and 76.67% in the control group. There was statistical difference between the two group (P<0.05, P<0.01). There was some improvement in the jaundice subside time, the retraction time for Gan and Pi, the body weight growth, the indices of the liver function in the two groups. Better results were obtained in the treatment group than in the control group, showing statistical difference (P<0.05, P<0.01). The lab indices of CMV infection showed negative to some degrees. The negative rates of serum IgM (83.54% in the treatment group and 63. 64% in the control group) and the serum CMVDNA (84.52% in the treatment group and 67.47% in the control group) were better in the treatment group than in the control group, showing statistical difference (P<0.01). There was no obvious difference in the negative rate of CMV antigen in urine between the two groups (P>0.05).
CONCLUSIONSLM combined ganciclovir therapy showed definite effects in treating cholestatic liver diseases caused by CMV infection. Early treatment for severe infants might change their prognosis. LM also could alleviate adverse reactions during the therapeutic course.
Cholestasis ; complications ; drug therapy ; virology ; Cytomegalovirus Infections ; drug therapy ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Ganciclovir ; therapeutic use ; Humans ; Infant ; Liver Diseases ; drug therapy ; etiology ; virology ; Male ; Phytotherapy
3.A Case of CMV Endotheliitis Treated with Intravitreal Ganciclovir Injection.
Won Seok CHOI ; Joon Hee CHO ; Ha Kyoung KIM ; Hyun Soo KIM ; Young Joo SHIN
Korean Journal of Ophthalmology 2013;27(2):130-132
We report a case of CMV corneal endotheliitis that was treated with intravitreal ganciclovir injection. A 56-year-old man who has suffered from uveitis was referred to our clinic due to corneal endothelial abnormality. Slit lamp examination showed a localized sectoral corneal edema and linear keratic precipitates along the boundary of edema. In spite of treatment with oral steroid and acyclovir, the disease progressed and two new coin-like lesions were developed. After topical ganciclovir and intavitreal injection of ganciclovir, the corneal lesions disappeared.
Antiviral Agents/administration & dosage
;
Cytomegalovirus Infections/*complications/*drug therapy
;
Endothelium, Corneal/*virology
;
Ganciclovir/*administration & dosage
;
Humans
;
Intravitreal Injections
;
Keratitis/*drug therapy/*virology
;
Male
;
Middle Aged
4.A Case of CMV Endotheliitis Treated with Intravitreal Ganciclovir Injection.
Won Seok CHOI ; Joon Hee CHO ; Ha Kyoung KIM ; Hyun Soo KIM ; Young Joo SHIN
Korean Journal of Ophthalmology 2013;27(2):130-132
We report a case of CMV corneal endotheliitis that was treated with intravitreal ganciclovir injection. A 56-year-old man who has suffered from uveitis was referred to our clinic due to corneal endothelial abnormality. Slit lamp examination showed a localized sectoral corneal edema and linear keratic precipitates along the boundary of edema. In spite of treatment with oral steroid and acyclovir, the disease progressed and two new coin-like lesions were developed. After topical ganciclovir and intavitreal injection of ganciclovir, the corneal lesions disappeared.
Antiviral Agents/administration & dosage
;
Cytomegalovirus Infections/*complications/*drug therapy
;
Endothelium, Corneal/*virology
;
Ganciclovir/*administration & dosage
;
Humans
;
Intravitreal Injections
;
Keratitis/*drug therapy/*virology
;
Male
;
Middle Aged
5.A 5-year retrospective clinical study of perinatal cytomegalovirus infection.
Li-Wei LIU ; Ji-Hong QIAN ; Tian-Wen ZHU ; Yong-Hong ZHANG ; Jian-Xing ZHU
Chinese Journal of Contemporary Pediatrics 2016;18(2):99-104
OBJECTIVETo investigate the incidence, clinical features, and treatment of perinatal cytomegalovirus (CMV) infection, as well as the factors affecting the therapeutic effect of ganciclovir.
METHODSThe clinical data of 237 infants who were hospitalized and diagnosed with perinatal CMV infection from 2008 to 2012 were retrospectively analyzed.
RESULTSThe clinical features of infants with perinatal CMV infection and the proportion of such infants in all hospitalized infants showed no significant differences across the five years. In most infants, two or more systems were involved, and CMV hepatitis plus CMV pneumonia was most common (43.1%). The results of pathogen detection showed that the percentage of the infants with positive blood CMV-IgM and blood/urine CMV-DNA was 3.8%, while 90.3% of all infants had positive blood CMV-IgM alone and 5.9% had positive blood/urine CMV-DNA alone. A total of 197 infants were treated with ganciclovir, and the cure rate was 88.3%. An abnormal history of pregnancy (OR=6.191, 95% CI: 1.597-24.002) and liver involvement before medication (OR=3.705, 95% CI: 1.537-8.931) were the independent risk factors affecting the therapeutic effect of ganciclovir in infants with perinatal CMV infection.
CONCLUSIONSThe epidemiological characteristics of perinatal CMV infection have remained generally stable for the last 5 years. CMV often involves several organs or systems, especially the liver and lung. Ganciclovir has a significant efficacy in the treatment of perinatal CMV infection, and an abnormal history of pregnancy and liver involvement before medication can increase the risk of ganciclovir resistance in infants with perinatal CMV infection.
Antiviral Agents ; therapeutic use ; Cytomegalovirus ; isolation & purification ; physiology ; Cytomegalovirus Infections ; drug therapy ; epidemiology ; virology ; Female ; Ganciclovir ; therapeutic use ; Humans ; Infant ; Infant, Newborn ; Infant, Newborn, Diseases ; drug therapy ; epidemiology ; virology ; Liver ; virology ; Male ; Retrospective Studies
6.Bicyclol combined with ganciclovir for treatment of infantile cytomegalovirus hepatitis.
Yan-Hong LIU ; Mei-Yun JIA ; Gui-Juan LIANG ; Hai-Shan GUAN ; An-Ping YAN
Journal of Southern Medical University 2015;35(10):1505-1507
OBJECTIVETo evaluate the therapeutic effects of bicyclol combined with ganciclocir on infantile cytomegalovirus hepatitis.
METHODSSeventy infants with cytomegalovirus hepatitis were randomized into treatment group (n=35) and control group (n=35) for a 2-week-long treatment with ganciclocir (5 mg/kg) with and without oral bicyclol (3 mg/kg, twice daily), respectively.
RESULTSIn both groups, significant changes occurred in the levels of alanine aminotransferase, alkaline phosphatase, serum total bilirubin, serum total bile acid, and glutamyl transpeptidase after the 2-week treatment (P<0.01); these parameters differed significantly between the two groups after the treatment (P<0.01). Compared with those in the control group, the infants in the treatment group showed significantly better responses to the treatment (P<0.05) with a significantly higher rate of serum anti CMV IgM negativity (P<0.05).
CONCLUSIONSBicyclol combined with ganciclocir can reduce glutamic pyruvic transaminase, alkaline phosphatase and serum total bilirubin, and decrease bile acid levels to lessen liver cell damage and promote the recovery of liver cells.
Alanine Transaminase ; metabolism ; Alkaline Phosphatase ; metabolism ; Antiviral Agents ; therapeutic use ; Bilirubin ; blood ; Biphenyl Compounds ; therapeutic use ; Cytomegalovirus ; Cytomegalovirus Infections ; drug therapy ; Drug Therapy, Combination ; Ganciclovir ; therapeutic use ; Hepatitis ; drug therapy ; virology ; Humans ; Infant ; Liver Function Tests
7.A study on the traditional Chinese medicine Jinyebaidu for prevention and treatment of intrauterine infection with guinea pigs cytomegalovirus.
Suhua, CHEN ; Jinwen, XIONG ; Wei, XING ; Liangzhen, WEN ; Haizhi, LIU ; Xinrong, WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2005;25(6):721-3
The purpose is to study the prophylactic and therapeutic effect of the traditional Chinese Medicine (TCM)-Jinyebaidu (JYBD) to guinea pig cytomegalovirus (GPCMV) intrauterine infection. The virus-free female and male guinea pigs were screened with nest-polymerase chain reaction (N-PCR). After inbred, pregnant guinea pigs were selected and divided into 3 groups randomly: 5 guniea pigs of the blank control group were not given either GPCMV or JYBD. 31 guniea pigs of the positive control group were inoculated 1 mL (10(7) TCID50) suspension of GPCMV intraperitoneal. 10 guniea pigs of the experimental group were inoculated GPCMV firstly and then perfused stomach with JYBD for 14 days (Dosage in accordance with the modulus of the weight ratio of human to guniea pig). The effects of JYBD on the intrauterine infection of GPCMV were observed. The results showed that JYBD could decrease the maternal infection rate from 100% (31/31) to 50% (5/10) (P < 0.001), the intrauterine infection rate from 100% (72/72) to 75% (21/28) (P < 0.001), and the rate of abnormal outcome of pregnancy from 64.4% (29/45) to 25.0% (7/28) (P < 0.001), the infective symptoms being relieved. It can be concluded that traditional Chinese medicine- JYBD can prevent and treat (GPCMV intrauterine infection, and can be expected a prophylactic drug for HCMV intrauterine infection.
Cytomegalovirus
;
Cytomegalovirus Infections/*drug therapy
;
Drugs, Chinese Herbal/*therapeutic use
;
Fetal Diseases/*drug therapy
;
Fetal Diseases/prevention & control
;
Fetal Diseases/virology
;
Phytotherapy
;
Pregnancy Complications, Infectious/*drug therapy
;
Random Allocation
8.Clinical investigation on the treatment of HCMV hepatitis in children.
Fen-hua CHEN ; Qing-wen WANG ; Si-nian PAN ; Hui-qin CHEN ; Jing-zhi JI ; Zheng-xian HE
Chinese Journal of Experimental and Clinical Virology 2004;18(1):76-79
OBJECTIVETo investigate the effective therapeutic method of human cytomegalovirus (HCMV) hepatitis in children.
METHODSTwenty-five children with HCMV hepatitis were randomly assigned to a treated group (n=13) or a control group (n=12). Both groups were treated with prednisone, glucurone, luminal and Xiaoyanlidanpian. But the treated group was given ganciclovir (GCV) + intravenous immunoglobulin (IVIG) in addition. Each infant of the two groups was checked for blood routine, liver function and HCMV copy numbers on admission and before discharge. They were seen at the third, sixth and ninth month after discharge. On each visit blood specimens were collected for HCMV copy numbers (fluorescence quantitative PCR, FQ-PCR).
RESULTSThe viral load of the treated group decreased significantly. A significant difference in viral copy numbers was found between the two groups on admission, discharge, and third, sixth and ninth month after discharge (P less than 0.001). The number of HCMV DNA copy fell to 10(3) copies/ml on discharge while that of the control group fell to the same level after the third month. The differences between the two groups in the length of hospitalization, time of initial jaundice disappearance and complete disappearance were statistically significant (P less than 0.05). The need for transfusion in the treated group was significantly less than that in the control group (chi-square=4.012, P less than 0.05).
CONCLUSIONCombination of GCV with a high dosage of IVIG to treat HCMV active infection could decrease viral load remarkably; The duration of disease, severity of symptoms, degree of anemia and the need for blood transfusion were reduced. No adverse effects related to the combination of GCV with IVIG therapy were observed.
Antiviral Agents ; therapeutic use ; Cytomegalovirus ; genetics ; Cytomegalovirus Infections ; drug therapy ; DNA, Viral ; analysis ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Ganciclovir ; therapeutic use ; Hepatitis, Viral, Human ; drug therapy ; virology ; Humans ; Immunoglobulins, Intravenous ; therapeutic use ; Infant ; Male ; Treatment Outcome
9.A case of CMV disease of the jejunum in a patient with non-Hodgkin's lymphoma.
Ki Ju HAN ; In Seob JUNG ; Chan Kyu KIM ; Sung Kyu PARK ; Dong Won KIM ; Seung Ho BAICK ; Jong Ho WON ; Dae Sik HONG ; Seung Duk HWANG ; Chul MOON ; Hee Sook PARK
The Korean Journal of Internal Medicine 1998;13(2):143-146
CMV infection may occur anywhere in the gastrointestinal tract. Among the small intestine, ileum is the most common site of CMV disease and infection of jejunum is a rare one in patients with CMV gastroenteritis. Although rare, the reason why the recognition of this diagnosis is important is that it cause the lethal hemorrhage and perforation of gastrointestinal tract when its diagnosis and treatment was delayed. Rapid diagnosis are able to using the immunohistochemical stain in shell vial culture of infected specimen or peripheral neutrophils preparation in viremic patients within 8 to 36 hours. The treatment of choice is antiviral agent or surgical resection. We experienced a case of CMV disease of jejunum in patient with non-Hodgkin's lymphoma who showed severe ulceration in jejunum and massive intestinal hemorrhage, and he survived after successful treatment with segmental resection of jejunum and intravenous ganciclovir.
Adult
;
Antiviral Agents/therapeutic use
;
Cytomegalovirus Infections/drug therapy
;
Cytomegalovirus Infections/diagnosis
;
Cytomegalovirus Infections/complications*
;
Disease-Free Survival
;
Enteritis/virology
;
Enteritis/surgery
;
Enteritis/complications
;
Ganciclovir/therapeutic use
;
Gastrointestinal Hemorrhage/therapy
;
Gastrointestinal Hemorrhage/etiology*
;
Gastrointestinal Hemorrhage/diagnosis
;
Human
;
Jejunal Diseases/virology
;
Jejunal Diseases/surgery
;
Jejunal Diseases/complications*
;
Lymphoma, Non-Hodgkin/drug therapy
;
Lymphoma, Non-Hodgkin/diagnosis
;
Lymphoma, Non-Hodgkin/complications*
;
Male
;
Opportunistic Infections/drug therapy
;
Opportunistic Infections/diagnosis
;
Opportunistic Infections/complications*
;
Substances: Ganciclovir
;
Substances: Antiviral Agents
10.Comparison of Quantitation of Cytomegalovirus DNA by Real-Time PCR in Whole Blood with the Cytomegalovirus Antigenemia Assay.
Seonhee KWON ; Bo Kyeung JUNG ; Sun Young KO ; Chang Kyu LEE ; Yunjung CHO
Annals of Laboratory Medicine 2015;35(1):99-104
BACKGROUND: Quantitation of cytomegalovirus (CMV) DNA using real-time PCR has been utilized for monitoring CMV infection. However, the CMV antigenemia assay is still the 'gold standard' assay. There are only a few studies in Korea that compared the efficacy of use of real-time PCR for quantitation of CMV DNA in whole blood with the antigenemia assay, and most of these studies have been limited to transplant recipients. METHOD: 479 whole blood samples from 79 patients, falling under different disease groups, were tested by real-time CMV DNA PCR using the Q-CMV real-time complete kit (Nanogen Advanced Diagnostic S.r.L., Italy) and CMV antigenemia assay (CINA Kit, ArgeneBiosoft, France), and the results were compared. Repeatedly tested patients were selected and their charts were reviewed for ganciclovir therapy. RESULTS: The concordance rate of the two assays was 86.4% (Cohen's kappa coefficient value=0.659). Quantitative correlation between the two assays was a moderate (r=0.5504, P<0.0001). Among 20 patients tested repeatedly with the two assays, 13 patients were transplant recipients and treated with ganciclovir. Before treatment, CMV was detected earlier by real-time CMV DNA PCR than the antigenemia assay, with a median difference of 8 days. After treatment, the antigenemia assay achieved negative results earlier than real-time CMV DNA PCR with a median difference of 10.5 days. CONCLUSIONS: Q-CMV real-time complete kit is a useful tool for early detection of CMV infection in whole blood samples in transplant recipients.
Antiviral Agents/therapeutic use
;
Cytomegalovirus/*genetics
;
Cytomegalovirus Infections/drug therapy/pathology/virology
;
DNA, Viral/*blood/metabolism
;
Ganciclovir/therapeutic use
;
Humans
;
*Immunoassay
;
Organ Transplantation
;
Phosphoproteins/genetics/immunology/*metabolism
;
*Real-Time Polymerase Chain Reaction
;
Viral Matrix Proteins/genetics/immunology/*metabolism
;
Virology/*methods